Literature DB >> 19555869

Polypharmacy in the elderly: focus on drug interactions and adherence in hypertension.

Danielle Cooney1, Kristina Pascuzzi.   

Abstract

Polypharmacy is highly prevalent in the elderly due to an increased number of co-morbid disease states that accompany aging. Hypertension is one common disease that can be challenging to treat in the elderly due to the body's physiologic changes, potential risks for side effects, medication interactions, and decreased medication adherence. A thorough medication assessment for each patient is essential when determining pharmacotherapeutic options in the elderly.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19555869     DOI： 10.1016/j.cger.2009.01.005

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN： 0749-0690            Impact factor:   3.076


  14 in total

Review 1.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

Review 2.  Dangers of Overly Aggressive Blood Pressure Control.

Authors:  Faisal Rahman; John W McEvoy
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

3.  Prevalence and Covariates of Polypharmacy in Elderly Patients on Discharge from a Tertiary 
Care Hospital in Oman.

Authors:  Amna Al-Hashar; Hamed Al Sinawi; Anwar Al Mahrizi; Manal Al-Hatrushi
Journal:  Oman Med J       Date:  2016-11

4.  Impact of specific Beers Criteria medications on associations between drug exposure and unplanned hospitalisation in elderly patients taking high-risk drugs: a case-time-control study in Western Australia.

Authors:  Sylvie D Price; C D'Arcy J Holman; Frank M Sanfilippo; Jon D Emery
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

5.  Medication adherence to multidrug regimens.

Authors:  Zachary A Marcum; Walid F Gellad
Journal:  Clin Geriatr Med       Date:  2012-05       Impact factor: 3.076

6.  Polypharmacy and nutritional status in older adults: a cross-sectional study.

Authors:  Roschelle A Heuberger; Karly Caudell
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

7.  Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.

Authors:  Chen-Fang Lin; Chun-Yu Wang; Chyi-Huey Bai
Journal:  Drugs Aging       Date:  2011-03-01       Impact factor: 3.923

8.  Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.

Authors:  Carol Holtzman; Carl Armon; Ellen Tedaldi; Joan S Chmiel; Kate Buchacz; Kathleen Wood; John T Brooks
Journal:  J Gen Intern Med       Date:  2013-04-20       Impact factor: 5.128

9.  Medication compliance and clinical outcomes of fixed-dose combinations vs free combinations of an angiotensin II receptor blocker and a calcium channel blocker in hypertension treatment.

Authors:  Ying-Chang Tung; Yu-Chang Huang; Lung-Sheng Wu; Chee-Jen Chang; Pao-Hsien Chu
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-05-30       Impact factor: 3.738

Review 10.  Polypharmacy in Older Adults With Hypertension: A Comprehensive Review.

Authors:  Bertrand N Mukete; Keith C Ferdinand
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-27       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.